Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Biokarpet S.A. (BIOKA.AT)
Larissa, GR
Biokarpet S.A. engages in the metallurgy, textile, and information technology sectors in Greece and internationally. It operates through Metallurgy, Textile, Information Technology, and Energy segments. The company is also involved in production and distribution of energy through renewable sources; production of textile products; sales of goods and provision of support from information systems; and production and trading of aluminum profile products and related products. The company was founded in 1970 and is headquartered in Athens, Greece.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.59% | +0.60% | +1.82% | -4.00% | -14.72% | -14.72% | -1.75% | -23.29% | +17.48% | +425.00% | +47.37% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Manufacturing - Metal Fabrication: +10.4%+3.7% Q4'25: +94.1% (vs Q2'24)
-
EPS growth Manufacturing - Metal Fabrication: +16.7%+931.8% ★ Q4'25: +13,420.0% (vs Q2'24)
-
FCF margin FCF growth · Manufacturing - Metal Fabrication: +40.8%-3.2% Q4'25: -14.8% (vs Q2'24)
-
EBIT margin Manufacturing - Metal Fabrication: +8.3%+2.3% Q4'25: +2.2% (vs Q2'24)
-
ROIC Manufacturing - Metal Fabrication: +6.2%+2.4% Q4'25: +4.5% (vs Q2'24)
-
Share dilution Manufacturing - Metal Fabrication: +0.0%+0.0% Q4'25: +0.0% (vs Q2'24)
-
Debt / EBITDA Net debt/EBITDA · Manufacturing - Metal Fabrication: 0.46×9.82× Q4'25: 5.05× (vs Q2'24)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B- | 3/5 | 1/5 | 3/5 | 3/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-28 | B- | 3/5 | 1/5 | 3/5 | 3/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-27 | B- | 3/5 | 1/5 | 3/5 | 3/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-26 | B- | 3/5 | 1/5 | 3/5 | 3/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-25 | B- | 3/5 | 1/5 | 3/5 | 3/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-22 | B- | 3/5 | 1/5 | 3/5 | 3/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-21 | B- | 3/5 | 1/5 | 3/5 | 3/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-20 | B- | 3/5 | 1/5 | 3/5 | 3/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-19 | B- | 3/5 | 1/5 | 3/5 | 3/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-18 | B- | 3/5 | 1/5 | 3/5 | 3/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-15 | B- | 3/5 | 1/5 | 3/5 | 3/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-14 | B- | 3/5 | 1/5 | 3/5 | 3/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-13 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-12 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-11 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-08 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-07 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-06 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-05 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-04 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-30 | B- | 3/5 | 1/5 | 2/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-29 | B- | 3/5 | 1/5 | 2/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-28 | B- | 3/5 | 1/5 | 2/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-27 | B- | 3/5 | 1/5 | 2/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-24 | B- | 3/5 | 1/5 | 2/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-23 | B- | 3/5 | 1/5 | 2/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-22 | B- | 3/5 | 1/5 | 2/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-21 | B- | 3/5 | 1/5 | 2/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-20 | B- | 3/5 | 1/5 | 2/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-17 | B- | 3/5 | 1/5 | 2/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-16 | B- | 3/5 | 1/5 | 2/5 | 4/5 | 1/5 | 3/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Athanasios Vasiliou Tsiaras | Chief Executive Officer & Executive Director | — | male |
| Dimitrios Sekkas | Financial Services Director | — | male |
| Georgios Antonios Kantonias | Chief Executive Officer & Executive Director | — | male |
| Ioannis Asterios Kantonias | Chairman of the Board & Chief Executive Officer | — | male |
| Konstantinos Velissariou | Regulatory Compliance Officer | — | male |
| Panagiotis Antonios Mauromatis | Executive Director | — | male |
| Prodromos Mich. Papadopoulos | Chief Accountant | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for BIOKA.AT
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
